Which oil has the highest concentration of linolenic acid?
Which of the following is a lipotropic factor?
Which of the following is required for fatty acid synthesis ?
Which of the following is not affected in Abetalipoproteinemia ?
The primary site of lipogenesis is:
Which of the following is a true difference between gangliosides and cerebrosides?
In which condition does serum appear milky white?
Which of the following fatty acids has the maximum number of carbon atoms?
Enzyme deficient in Type I Hyperlipidemia?
What is the primary product of fatty acid oxidation (β-oxidation)?
Explanation: ***Soyabean oil*** - **Soyabean oil** contains approximately **7-10% linolenic acid (C18:3)**, an omega-3 fatty acid. - Among the given options, it has the **highest concentration** of this essential fatty acid. - **Linolenic acid** is crucial for **heart health** and **reducing inflammation**. *Coconut oil* - **Coconut oil** is primarily composed of **saturated fatty acids**, notably **lauric acid (C12:0)**. - It contains **negligible amounts** of **linolenic acid** (<0.5%). *Groundnut oil* - **Groundnut oil** (peanut oil) is rich in **oleic acid (C18:1)** and **linoleic acid (C18:2)**. - Its concentration of **linolenic acid** is very low (**~0.5-1%**), much lower than soyabean oil. *Safflower oil* - **Safflower oil** is known for its high content of **linoleic acid (C18:2)**, an omega-6 fatty acid. - It contains **minimal amounts** of **linolenic acid** (<1%).
Explanation: ***Methionine*** - **Methionine** is an essential amino acid that serves as a precursor for **choline** and **creatine**, both of which play crucial roles in lipid metabolism and transport. - Lipotropic factors prevent or reverse the accumulation of **fat in the liver** by promoting the synthesis of **lipoproteins**, which package and transport fats from the liver to other tissues. *Sphingomyelin* - **Sphingomyelin** is a type of **sphingolipid**, a component of cell membranes and myelin sheaths, but it does not directly act as a lipotropic factor to prevent fatty liver. - While it's involved in cellular signaling and membrane structure, it does not directly facilitate the metabolism or transport of **hepatic triglycerides** in the same way as lipotropic agents. *Histidine* - **Histidine** is an essential amino acid involved in protein synthesis and the production of **histamine**, but it is not considered a primary lipotropic factor. - Its main roles are in **immune response** and **neurotransmission**, not in preventing fat accumulation in the liver. *Bilirubin* - **Bilirubin** is a waste product from the breakdown of **heme**, primarily from red blood cells. It is excreted by the liver. - It is known for its **antioxidant properties** but does not play a direct role as a lipotropic factor in lipid metabolism or in preventing **fatty liver**.
Explanation: ***NADPH*** - **NADPH** is crucial for fatty acid synthesis, providing the **reducing power** needed for the successive reduction steps. - The enzymes involved, such as **fatty acid synthase**, utilize **NADPH** for the conversion of keto groups to hydroxyl groups and then to saturated methylene groups. *NADH* - **NADH** plays a primary role in **oxidative phosphorylation** and the electron transport chain to generate ATP. - It is generally produced during **catabolic reactions** and is not primarily used as a reducing agent in anabolic processes like fatty acid synthesis. *FADH* - **FADH2** (reduced form of FAD, not FADH) is a coenzyme involved in redox reactions, particularly in the **Krebs cycle** and beta-oxidation of fatty acids. - Like NADH, it is mostly involved in **catabolic processes** that generate energy, rather than anabolic processes requiring reducing equivalents for synthesis. *None of the options* - This option is incorrect because **NADPH** is indeed required for fatty acid synthesis, serving as the essential reducing agent. - The other coenzymes mentioned (NADH, FADH) have different metabolic roles, primarily in energy production rather than biosynthesis.
Explanation: ***HDL*** - **Abetalipoproteinemia** is caused by a defect in the **microsomal triglyceride transfer protein (MTP)**, which is essential for the assembly and secretion of **chylomicrons**, **VLDL**, and subsequently **LDL** and **IDL**. - **HDL synthesis** and secretion occur independently of MTP, as nascent HDL particles are formed in the plasma from lipids and apolipoproteins (primarily apoA-I) released from other lipoproteins and cells. *LDL* - **LDL** is critically affected in abetalipoproteinemia because it is a metabolic product of **VLDL**. - Since **VLDL** production is severely impaired due to the MTP defect, there is a profound deficiency of **LDL** in the plasma. *VLDL* - **VLDL** production is severely impaired in abetalipoproteinemia because **microsomal triglyceride transfer protein (MTP)** is required for its assembly and secretion from the liver. - The inability to load triglycerides onto apoB leads to very low or absent plasma **VLDL** levels. *IDL* - **IDL** is an intermediate lipoprotein in the metabolism of **VLDL** to **LDL**. - Given that both **VLDL** and **LDL** are severely deficient in abetalipoproteinemia, **IDL** levels are also consequently very low or absent.
Explanation: ***Liver*** - The **liver** is the principal organ for **de novo lipogenesis**, converting excess carbohydrates into fatty acids and triglycerides. - This process is highly active in response to a high-carbohydrate diet, with the synthesized lipids packaged into **VLDL** for transport. *Skeletal muscles* - **Skeletal muscles** primarily utilize fatty acids for **energy production** rather than synthesizing large amounts of new lipids. - While they can store some triglycerides, their capacity for de novo lipogenesis is significantly lower compared to the liver. *Myocardium* - The **myocardium** (heart muscle) primarily relies on fatty acids for its continuous **energy demands** and has limited capacity for de novo lipogenesis. - Its metabolic focus is on efficient **ATP generation** to maintain cardiac function. *Lungs* - The **lungs** are not a primary site for general lipogenesis, though they are involved in the synthesis of specific lipids like **surfactant**. - Surfactant synthesis is a specialized process crucial for lung function, distinct from general energy storage lipogenesis.
Explanation: ***Charge difference*** - **Gangliosides** contain **sialic acid (N-acetylneuraminic acid)** residues, which are negatively charged, making gangliosides **anionic**. - **Cerebrosides** are **neutral glycosphingolipids** as they lack charged sugar residues. *Specific carbohydrate composition* - While both have carbohydrate components, referring to "specific carbohydrate composition" as the *true difference* is too broad. Both have characteristic sugar groups, but the **presence of sialic acid** in gangliosides is the key differentiator in charge. - Cerebrosides typically contain a single sugar (either glucose or galactose), whereas gangliosides have a more complex oligosaccharide chain including sialic acid. *Presence of glucose* - Both cerebrosides (specifically **glucocerebrosides**) and gangliosides can contain **glucose** in their carbohydrate moieties. - This is not a distinguishing feature; the *type* and *arrangement* of sugars, particularly the presence of sialic acid, are more specific. *Location in the nervous system* - Both gangliosides and cerebrosides are abundant in the **nervous system**, particularly in cell membranes. - Their presence in the nervous system is a similarity, not a differentiating factor.
Explanation: ***Increased Chylomicrons*** - **Chylomicrons** are the largest lipoprotein particles (75-1200 nm) with the highest **triglyceride content (85-95%)**, giving serum a characteristic **milky white** or "creamy" appearance - This intense milky appearance occurs after **fatty meals** (postprandial lipemia) or in **Type I and V hyperlipidemias** (familial chylomicronemia syndrome) - The **light scattering** by these large particles makes the serum completely opaque, distinguishing it from other lipid abnormalities - Classic clinical finding: **"cream layer" forms on top** when lipemic serum stands overnight in refrigerator *Increased LDL* - Elevated **Low-Density Lipoprotein (LDL)** produces **clear to slightly hazy** serum, never milky white - LDL particles are much smaller (18-25 nm) than chylomicrons and contain primarily **cholesterol**, not triglycerides - High LDL is a cardiovascular risk factor but does not cause visible lipemia *Increased HDL* - **High-Density Lipoprotein (HDL)** elevation results in **clear serum** - HDL particles are the smallest (5-12 nm) and densest lipoproteins - High HDL is protective and causes no turbidity *Increased VLDL* - **Very Low-Density Lipoprotein (VLDL)** elevation can cause **turbid or hazy** serum in severe hypertriglyceridemia, but typically less intensely milky than chylomicrons - VLDL particles are smaller (30-80 nm) than chylomicrons with lower triglyceride content (50-65%) - In Type IV hyperlipidemia (isolated VLDL elevation), serum appears uniformly turbid without cream layer formation - The most dramatic "milky white" appearance is specifically associated with **chylomicronemia**
Explanation: **Cervonic acid** - **Cervonic acid**, also known as **docosahexaenoic acid (DHA)**, is a long-chain omega-3 fatty acid with **22 carbon atoms** and 6 double bonds (22:6). - It is a primary structural component of the brain and retina and is the longest fatty acid among the options provided. *Oleic acid* - **Oleic acid** is a monounsaturated fatty acid with **18 carbon atoms** and one double bond (18:1). - It is a common fatty acid found in many animal fats and vegetable oils, but it has fewer carbon atoms than cervonic acid. *Linolenic acid* - **Linolenic acid** refers to two essential fatty acids: alpha-linolenic acid (ALA) and gamma-linolenic acid (GLA). Both have **18 carbon atoms**. - Alpha-linolenic acid (ALA) is an omega-3 fatty acid with 3 double bonds (18:3), while gamma-linolenic acid (GLA) is an omega-6 fatty acid with 3 double bonds (18:3), neither of which has more carbon atoms than cervonic acid. *Arachidonic acid* - **Arachidonic acid** is an omega-6 fatty acid with **20 carbon atoms** and four double bonds (20:4). - It is a precursor to eicosanoids and is longer than oleic and linolenic acids but shorter than cervonic acid.
Explanation: ***Lipoprotein lipase*** - **Type I hyperlipidemia**, also known as **familial hyperchylomicronemia**, is characterized by a deficiency in **lipoprotein lipase (LPL)**. - LPL is crucial for hydrolyzing triglycerides in **chylomicrons** and **VLDLs** into fatty acids and glycerol, allowing their uptake by tissues. *HMG CoA reductase* - This enzyme is involved in the **rate-limiting step of cholesterol synthesis** in the liver. - While it plays a role in lipid metabolism, its deficiency is not characteristic of **Type I hyperlipidemia**. *Peroxidase* - **Peroxidase** is an enzyme involved in various oxidative reactions, including the breakdown of **hydrogen peroxide**. - It is not directly involved in the metabolism of **chylomicrons** or **triglycerides**, and its deficiency is unrelated to hyperlipidemia. *Cholesterol acyl transferase* - This enzyme, often referring to **lecithin-cholesterol acyltransferase (LCAT)** or **acyl-CoA:cholesterol acyltransferase (ACAT)**, is involved in **cholesterol esterification**. - While important for cholesterol transport and storage, its deficiency is not the primary cause of **Type I hyperlipidemia**, which is marked by severe **chylomicronemia**.
Explanation: ***Acetyl CoA*** - Beta-oxidation of fatty acids involves a series of reactions that cleave two-carbon units from the fatty acyl chain, forming **acetyl CoA**. - **Acetyl CoA** is the direct product of each cycle of β-oxidation and then enters the **citric acid cycle** to generate ATP or serves as a precursor for other anabolic pathways. *Malonyl CoA* - **Malonyl CoA** is a key intermediate in **fatty acid synthesis**, not degradation. - It's formed from acetyl CoA by acetyl-CoA carboxylase and acts as a substrate for **fatty acid synthase**, and also as a physiological inhibitor of carnitine palmitoyltransferase I (CPT-I), thereby regulating β-oxidation. *Ketone bodies* - **Ketone bodies** (**acetoacetate** and **β-hydroxybutyrate**) are produced from acetyl CoA in the liver during conditions of low glucose availability or prolonged fasting. - They serve as an alternative fuel source for tissues like the brain and muscles, but are secondary products derived from the condensation of acetyl CoA molecules, not the primary direct product of fatty acid breakdown itself. *Cholesterol* - **Cholesterol** is a steroid lipid synthesized from **acetyl CoA** through a complex multi-step pathway (via HMG-CoA reductase pathway). - It is an important structural component of cell membranes and a precursor for steroid hormones and bile acids, but not a direct product of fatty acid catabolism.
Lipid Classification and Chemistry
Practice Questions
Fatty Acid Oxidation
Practice Questions
Ketone Body Metabolism
Practice Questions
Fatty Acid Synthesis
Practice Questions
Metabolism of Triacylglycerols
Practice Questions
Phospholipid Metabolism
Practice Questions
Cholesterol Metabolism and Biosynthesis
Practice Questions
Bile Acids and Bile Salts
Practice Questions
Lipoprotein Metabolism and Transport
Practice Questions
Dyslipidemias and Atherosclerosis
Practice Questions
Prostaglandins and Eicosanoids
Practice Questions
Fatty Liver and Lipotropic Factors
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free